Wockhardt’s Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk’s Ozempic, Zaynich’s $25 billion potential counters global antibiotic resistance.
Localisation lens on 500 most-imported items: DPIIT analysing data; move aims to reduce country’s import bill
The Indian government is scrutinizing over 500 imported products, including machinery, fertilizers, and electronics, to identify opportunities for domestic manufacturing and reduce reliance on foreign